Cleared Abbreviated

K120771 - UNICEL DXH 800 COULTER CELLULAR ANALYSI...

K120771 is the FDA 510(k) clearance for UNICEL DXH 800 COULTER CELLULAR ANALYSI... by Beckman Coulter, Inc.. It is a Class 2 Hematology device (product code GKZ) cleared through the Abbreviated 510(k) pathway after a 373-day FDA review.

K120771 · Beckman Coulter, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2013
Decision
373d
Days
Class 2
Risk

K120771 is an FDA 510(k) clearance for the UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Beckman Coulter, Inc. (Miami, US). The FDA issued a Cleared decision on March 22, 2013 after a review of 373 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Beckman Coulter, Inc. devices

Submission Details

510(k) Number K120771 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 14, 2012
Decision Date March 22, 2013
Days to Decision 373 days
Submission Type Abbreviated
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
260d slower than avg
Panel avg: 113d · This submission: 373d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 151
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K120771.
UniCel DxH SlideMaker Stainer Coulter Cellular Analysis System
K162414 · Beckman Coulter, Inc. · Nov 2016
XW-100 Automated Hematology Analyzer, XW QC CHECK
K143577 · Sysmex America, Inc. · Oct 2015
UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM/ UNICEL DXH SLIDEMAKER STAINER COULTER CELLULAR ANALYSIS SYSTEM
K140911 · Beckman Coulter, Inc. · Sep 2014
CELL-DYN EMERALD 22 SYSTEM
K110381 · Abbott Laboratories · Dec 2011
ADVIA 2120 WITH AUTOSLIDE SYSTEM, AND ADVIA 2120I
K102644 · Siemens Healthcare Diagnostics · Nov 2011
BD FACS SAMPLE PREP ASSISTANT III (SPA III)
K102064 · Becton, Dickinson & CO · Mar 2011